{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:43:32Z","timestamp":1792539812106,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T00:00:00Z","timestamp":1273536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s12185-010-0586-9","type":"journal-article","created":{"date-parts":[[2010,5,10]],"date-time":"2010-05-10T05:02:11Z","timestamp":1273467731000},"page":"903-906","source":"Crossref","is-referenced-by-count":31,"title":["Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma"],"prefix":"10.1007","volume":"91","author":[{"given":"Hiroyuki","family":"Takamatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeharu","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Sawazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,11]]},"reference":[{"key":"586_CR1","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/blood-2006-08-036947","volume":"110","author":"PG Richardson","year":"2007","unstructured":"Richardson PG, Sonneveld P, Schuster M, Irwin D, Stadtmauer E, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Miguel JS, Blade J, Boccadoro M, Cavenagh J, Alsina M, Rajkumar SV, Lacy M, Jakubowiak A, Dalton W, Boral A, Esseltine DL, Schenkein D, Anderson KC. Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial. Blood. 2007;110:3557\u201360.","journal-title":"Blood"},{"issue":"Suppl 1","key":"586_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0305-7372(03)00080-X","volume":"29","author":"P Richardson","year":"2003","unstructured":"Richardson P. Clinical update: proteasome inhibitors in hematologic malignancies. Cancer Treat Rev. 2003;29(Suppl 1):33\u20139.","journal-title":"Cancer Treat Rev"},{"key":"586_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3816\/CLM.2006.n.050","volume":"7","author":"A Suvannasankha","year":"2006","unstructured":"Suvannasankha A, Smith GG, Juliar BE, Abonour R. Weekly bortezomib\/methylprednisolone is effective and well tolerated in relapsed multiple myeloma. Clin Lymphoma Myeloma. 2006;7:131\u20134.","journal-title":"Clin Lymphoma Myeloma"},{"key":"586_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2407-6-129","volume":"6","author":"J Voortman","year":"2006","unstructured":"Voortman J, Giaccone G. Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report. BMC Cancer. 2006;6:129.","journal-title":"BMC Cancer"},{"key":"586_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12185-008-0139-7","volume":"88","author":"A Hacihanefioglu","year":"2008","unstructured":"Hacihanefioglu A, Tarkun P, Gonullu E. Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib. Int J Hematol. 2008;88:219\u201322.","journal-title":"Int J Hematol"},{"key":"586_CR6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2141.2007.06659.x","volume":"138","author":"E Orciuolo","year":"2007","unstructured":"Orciuolo E, Buda G, Cecconi N, Galimberti S, Versari D, Cervetti G, Salvetti A, Petrini M. Unexpected cardiotoxicity in haematological bortezomib treated patients. Br J Haematol. 2007;138:396\u20137.","journal-title":"Br J Haematol"},{"key":"586_CR7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2459\/JCM.0b013e32832f3ff2","volume":"11","author":"PW Foley","year":"2010","unstructured":"Foley PW, Hamilton MS, Leyva F. Myocardial scarring following chemotherapy for multiple myeloma detected using late gadolinium hyperenhancement cardiovascular magnetic resonance. J Cardiovasc Med (Hagerstown). 2010;11:386\u20138.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"586_CR8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2141.2000.02120.x","volume":"109","author":"M Wada","year":"2000","unstructured":"Wada M, Mizoguchi H, Kuriya SI, Taguchi H, Kawamura T, Maekawa I, Shimazaki C, Sato Y, Niho Y, Miyazaki T, Shibata A, Kitani T, Hamajima N, Ohno R. Induction therapy consisting of alternating cycles of ranimustine, vincristine, melphalan, dexamethasone and interferon alpha (ROAD-IN) and a randomized comparison of interferon alpha maintenance in multiple myeloma: a co-operative study in Japan. Br J Haematol. 2000;109:805\u201314.","journal-title":"Br J Haematol"},{"key":"586_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0609.2006.00774.x","volume":"78","author":"M Martino","year":"2007","unstructured":"Martino M, Console G, Callea V, Stelitano C, Massara E, Irrera G, Messina G, Morabito F, Iacopino P. Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients. Eur J Haematol. 2007;78:35\u201340.","journal-title":"Eur J Haematol"},{"key":"586_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(09)70284-0","volume":"11","author":"SV Rajkumar","year":"2010","unstructured":"Rajkumar SV, Jacobus S, Callander NS, Fonseca R, Vesole DH, Williams ME, Abonour R, Siegel DS, Katz M, Greipp PR. Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial. Lancet Oncol. 2010;11:29\u201337.","journal-title":"Lancet Oncol"},{"key":"586_CR11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1160\/TH04-10-0652","volume":"94","author":"B Jilma","year":"2005","unstructured":"Jilma B, Cvitko T, Winter-Fabry A, Petroczi K, Quehenberger P, Blann AD. High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men. Thromb Haemost. 2005;94:797\u2013801.","journal-title":"Thromb Haemost"},{"key":"586_CR12","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa0806576","volume":"359","author":"JM Miller","year":"2008","unstructured":"Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, Paul N, Clouse ME, Shapiro EP, Hoe J, Lardo AC, Bush DE, de Roos A, Cox C, Brinker J, Lima JA. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359:2324\u201336.","journal-title":"N Engl J Med"},{"key":"586_CR13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00330-008-1203-7","volume":"19","author":"JM Miller","year":"2009","unstructured":"Miller JM, Dewey M, Vavere AL, Rochitte CE, Niinuma H, Arbab-Zadeh A, Paul N, Hoe J, de Roos A, Yoshioka K, Lemos PA, Bush DE, Lardo AC, Texter J, Brinker J, Cox C, Clouse ME, Lima JA. Coronary CT angiography using 64 detector rows: methods and design of the multi-centre trial CORE-64. Eur Radiol. 2009;19:816\u201328.","journal-title":"Eur Radiol"},{"key":"586_CR14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1253\/circj.CJ-08-0940","volume":"73","author":"M Nagao","year":"2009","unstructured":"Nagao M, Matsuoka H, Kawakami H, Higashino H, Mochizuki T, Ohshita A, Kohno T, Shigemi S. Detection of myocardial ischemia using 64-slice MDCT. Circ J. 2009;73:905\u201311.","journal-title":"Circ J"},{"key":"586_CR15","first-page":"385","volume":"25","author":"XS Hu","year":"2010","unstructured":"Hu XS, Du CQ, Yang L, Yao XY, Hu SJ. Proteasome inhibitor MG132 suppresses number and function of endothelial progenitor cells: involvement of nitric oxide synthase inhibition. Int J Mol Med. 2010;25:385\u201392.","journal-title":"Int J Mol Med"},{"key":"586_CR16","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.99.22.2864","volume":"99","author":"M Nakayama","year":"1999","unstructured":"Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K. T-786\u2013\u00a0>\u00a0C mutation in the 5\u2019-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99:2864\u201370.","journal-title":"Circulation"},{"key":"586_CR17","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/S0024-3205(03)00644-1","volume":"73","author":"R Govers","year":"2003","unstructured":"Govers R, de Bree P, Rabelink TJ. Involvement of the proteasome in activation of endothelial nitric oxide synthase. Life Sci. 2003;73:2225\u201336.","journal-title":"Life Sci"},{"key":"586_CR18","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.yexcr.2009.11.005","volume":"316","author":"D Belloni","year":"2010","unstructured":"Belloni D, Veschini L, Foglieni C, Dell\u2019Antonio G, Caligaris-Cappio F, Ferrarini M, Ferrero E. Bortezomib induces autophagic death in proliferating human endothelial cells. Exp Cell Res. 2010;316:1010\u20138.","journal-title":"Exp Cell Res"},{"key":"586_CR19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/hc0402.102951","volume":"105","author":"S Meiners","year":"2002","unstructured":"Meiners S, Laule M, Rother W, Guenther C, Prauka I, Muschick P, Baumann G, Kloetzel PM, Stangl K. Ubiquitin\u2013proteasome pathway as a new target for the prevention of restenosis. Circulation. 2002;105:483\u20139.","journal-title":"Circulation"},{"key":"586_CR20","first-page":"61","volume":"66","author":"W Martinet","year":"2004","unstructured":"Martinet W, Kockx MM. Apoptosis in atherosclerosis: implications for plaque destabilization. Verh K Acad Geneeskd Belg. 2004;66:61\u201379.","journal-title":"Verh K Acad Geneeskd Belg"},{"key":"586_CR21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1538-7836.2005.01120.x","volume":"3","author":"MM Kavurma","year":"2005","unstructured":"Kavurma MM, Bhindi R, Lowe HC, Chesterman C, Khachigian LM. Vessel wall apoptosis and atherosclerotic plaque instability. J Thromb Haemost. 2005;3:465\u201372.","journal-title":"J Thromb Haemost"},{"key":"586_CR22","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.ATV.0000232501.08576.73","volume":"26","author":"D Versari","year":"2006","unstructured":"Versari D, Herrmann J, Gossl M, Mannheim D, Sattler K, Meyer FB, Lerman LO, Lerman A. Dysregulation of the ubiquitin\u2013proteasome system in human carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:2132\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0586-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-010-0586-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0586-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T03:22:50Z","timestamp":1685589770000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-010-0586-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,11]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1007\/s12185-010-0586-9","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,11]]}}}